AI Maverick Intel Inc AIMV

$0.06 +0.01 (20.24%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
PE ratio
—
Forward PE
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
100
Avg volume
29,164
Day's range
$0.06 – $0.06
Shares out
—
Stochastic %K
31%
Beta
—
Analysts
Strong Buy
Price target
—

Price

Company profile

AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. and changed its name to...

Show more

AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. and changed its name to AI Maverick Intel, Inc. in April 2025. AI Maverick Intel, Inc. was incorporated in 2006 and is based in Beverly Hills, California.

Industry
Medical Devices
Sector
Healthcare
Phone
800 784 7641
Website
https://aimaverickintel.com
Address
433 North Camden, Beverly Hills, United States

Latest news

No headlines yet.